318 related articles for article (PubMed ID: 19624269)
1. Comparative serum proteome analysis of human lymph node negative/positive invasive ductal carcinoma of the breast and benign breast disease controls via label-free semiquantitative shotgun technology.
Hu X; Zhang Y; Zhang A; Li Y; Zhu Z; Shao Z; Zeng R; Xu LX
OMICS; 2009 Aug; 13(4):291-300. PubMed ID: 19624269
[TBL] [Abstract][Full Text] [Related]
2. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
[TBL] [Abstract][Full Text] [Related]
3. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
[TBL] [Abstract][Full Text] [Related]
4. Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue.
Röwer C; Vissers JP; Koy C; Kipping M; Hecker M; Reimer T; Gerber B; Thiesen HJ; Glocker MO
Anal Bioanal Chem; 2009 Dec; 395(8):2443-56. PubMed ID: 19876624
[TBL] [Abstract][Full Text] [Related]
5. Comparative membrane proteomics analyses of breast cancer cell lines to understand the molecular mechanism of breast cancer brain metastasis.
Peng W; Zhang Y; Zhu R; Mechref Y
Electrophoresis; 2017 Sep; 38(17):2124-2134. PubMed ID: 28523741
[TBL] [Abstract][Full Text] [Related]
6. Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion.
Milioli HH; Santos Sousa K; Kaviski R; Dos Santos Oliveira NC; De Andrade Urban C; De Lima RS; Cavalli IJ; De Souza Fonseca Ribeiro EM
Cancer Genomics Proteomics; 2015; 12(2):89-101. PubMed ID: 25770193
[TBL] [Abstract][Full Text] [Related]
7. Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry.
Alldridge L; Metodieva G; Greenwood C; Al-Janabi K; Thwaites L; Sauven P; Metodiev M
J Proteome Res; 2008 Apr; 7(4):1458-69. PubMed ID: 18257521
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of breast cancer tissues to identify biomarker candidates by gel-assisted digestion and label-free quantification methods using LC-MS/MS.
Song MN; Moon PG; Lee JE; Na M; Kang W; Chae YS; Park JY; Park H; Baek MC
Arch Pharm Res; 2012 Oct; 35(10):1839-47. PubMed ID: 23139137
[TBL] [Abstract][Full Text] [Related]
9. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
Turtoi A; Mazzucchelli GD; De Pauw E
Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
[TBL] [Abstract][Full Text] [Related]
10. Identification of differentially secreted biomarkers using LC-MS/MS in isogenic cell lines representing a progression of breast cancer.
Mbeunkui F; Metge BJ; Shevde LA; Pannell LK
J Proteome Res; 2007 Aug; 6(8):2993-3002. PubMed ID: 17608509
[TBL] [Abstract][Full Text] [Related]
11. Proteomic profiling of infiltrating ductal carcinoma reveals increased cellular interactions with tissue microenvironment.
Gormley M; Tchafa A; Meng R; Zhong Z; Quong AA
J Proteome Res; 2012 Apr; 11(4):2236-46. PubMed ID: 22356716
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling and interactome analysis of ER-positive/HER2/neu negative invasive ductal carcinoma of the breast: towards proteomics biomarkers.
Korwar AM; Bhonsle HS; Ghole VS; Gawai KR; Koppikar CB; Kulkarni MJ
OMICS; 2013 Jan; 17(1):27-40. PubMed ID: 23301641
[TBL] [Abstract][Full Text] [Related]
13. Identification of vascular breast tumor markers by laser capture microdissection and label-free LC-MS.
Hill JJ; Tremblay TL; Pen A; Li J; Robotham AC; Lenferink AE; Wang E; O'Connor-McCourt M; Kelly JF
J Proteome Res; 2011 May; 10(5):2479-93. PubMed ID: 21401208
[TBL] [Abstract][Full Text] [Related]
14. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
[TBL] [Abstract][Full Text] [Related]
15. Quantitative label-free mass spectrometry using contralateral and adjacent breast tissues reveal differentially expressed proteins and their predicted impacts on pathways and cellular functions in breast cancer.
Gomig THB; Cavalli IJ; Souza RLR; Vieira E; Lucena ACR; Batista M; Machado KC; Marchini FK; Marchi FA; Lima RS; de Andrade Urban C; Cavalli LR; Ribeiro EMSF
J Proteomics; 2019 May; 199():1-14. PubMed ID: 30772490
[TBL] [Abstract][Full Text] [Related]
16. Primary study of lymph node metastasis-related serum biomarkers in breast cancer.
Wang L; Su D; Yan HJ; Xu JH; Zheng ZG; Hu YJ; Pan XD; Ding XW; Chen C; Chen B; Mao WM; Meng XL
Anat Rec (Hoboken); 2011 Nov; 294(11):1818-24. PubMed ID: 21964916
[TBL] [Abstract][Full Text] [Related]
17. Immunoproteomics of HER2-positive and HER2-negative breast cancer patients with positive lymph nodes.
Mojtahedi Z; Safaei A; Yousefi Z; Ghaderi A
OMICS; 2011 Jun; 15(6):409-18. PubMed ID: 21568730
[TBL] [Abstract][Full Text] [Related]
18. Label-Free Quantitative Proteomic Screening of Candidate Plasma Biomarkers for the Prognosis of Breast Cancer with Different Lymph Node Statuses.
Chen L; Zhao W; He J; Li L; Meng D; Cai D; Yu J; Chen D; Wu Y; Zhou T
Proteomics Clin Appl; 2018 May; 12(3):e1700117. PubMed ID: 29384592
[TBL] [Abstract][Full Text] [Related]
19. Label-free semiquantitative peptide feature profiling of human breast cancer and breast disease sera via two-dimensional liquid chromatography-mass spectrometry.
Ru QC; Zhu LA; Silberman J; Shriver CD
Mol Cell Proteomics; 2006 Jun; 5(6):1095-104. PubMed ID: 16546996
[TBL] [Abstract][Full Text] [Related]
20. Serum proteome analysis for profiling protein markers associated with lymph node metastasis in colorectal carcinoma.
Zhao L; Liu Y; Sun X; Peng K; Ding Y
J Comp Pathol; 2011; 144(2-3):187-94. PubMed ID: 21074777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
